George Pentheroudakis
Overview
Explore the profile of George Pentheroudakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
187
Citations
2905
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zerdes I, Filis P, Fountoukidis G, El-Naggar A, Kalofonou F, DAlessio A, et al.
J Natl Cancer Inst
. 2025 Jan;
PMID: 39842854
Background: Although precision oncology has rapidly been developed in recent years, its real-world impact and challenges in healthcare implementation remain underexplored. Through a meta-analysis of real-world evidence (RWE), we aimed...
2.
Filis P, Markozannes G, Chan D, Mauri D, Foukakis T, Matikas A, et al.
Crit Rev Oncol Hematol
. 2024 Dec;
207:104602.
PMID: 39730034
Background: To contribute to the refinement of future physical activity (PA) guidelines, which have remained mostly generic until now, we performed an umbrella review of meta-analyses for PA in cancer...
3.
Mountzios G, Koumarianou A, Linardou H, Boutis A, Mavroudis D, Samantas E, et al.
Anticancer Res
. 2023 Apr;
43(5):2243-2258.
PMID: 37097667
Background/aim: Real-world data on the EGFR mutational profile upon progression after first/second-generation EGFR-TKI treatment in patients with advanced non-small-cell lung cancer (NSCLC) and treatment strategies employed thereon are needed. Patients...
4.
Cortellini A, Dettorre G, Dafni U, Aguilar-Company J, Castelo-Branco L, Lambertini M, et al.
J Immunother Cancer
. 2022 Nov;
10(11).
PMID: 36450384
Background: As management and prevention strategies against COVID-19 evolve, it is still uncertain whether prior exposure to immune checkpoint inhibitors (ICIs) affects COVID-19 severity in patients with cancer. Methods: In...
5.
Wysocki O, Zhou C, Rogado J, Huddar P, Shotton R, Tivey A, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36010932
Patients with cancer have been shown to have increased risk of COVID-19 severity. We previously built and validated the COVID-19 Risk in Oncology Evaluation Tool (CORONET) to predict the likely...
6.
Siafaka V, Mavridis D, Tsonis O, Tzamakou E, Christogiannis C, Tefa L, et al.
Palliat Support Care
. 2022 Aug;
22(4):698-708.
PMID: 35983635
Objectives: Assessment of the psychometric characteristics of the Greek version of the brief World Health Organization Quality of Life Instrument (WHOQOL-BREF) in patients with advanced cancer and pain, and exploration...
7.
Lee R, Wysocki O, Zhou C, Shotton R, Tivey A, Lever L, et al.
JCO Clin Cancer Inform
. 2022 May;
6:e2100177.
PMID: 35609228
Purpose: Patients with cancer are at increased risk of severe COVID-19 disease, but have heterogeneous presentations and outcomes. Decision-making tools for hospital admission, severity prediction, and increased monitoring for early...
8.
Kastrisiou M, Zarkavelis G, Kougioumtzi A, Sakaloglou P, Kostoulas C, Georgiou I, et al.
Diagnostics (Basel)
. 2021 Dec;
11(12).
PMID: 34943612
The detection of actionable mutations in tumor tissue is a prerequisite for treatment customization in patients with metastatic colorectal cancer (mCRC). Analysis of circulating tumor DNA (ctDNA) for the identification...
9.
Rapti V, Moirogiorgou E, Koliou G, Papadopoulou K, Binas I, Pentheroudakis G, et al.
Oncol Lett
. 2021 Dec;
23(1):23.
PMID: 34868360
Prognostic and predictive biomarkers are being studied for the diagnosis and treatment of breast cancer. The present study retrospectively assessed the mRNA expression of HER family receptor ligands and of...
10.
Kourea H, Dimitrakopoulos F, Koliou G, Batistatou A, Papadopoulou K, Bobos M, et al.
Cancer Res Treat
. 2021 Nov;
54(4):1053-1064.
PMID: 34793664
Purpose: Angiogenesis is a crucial phenomenon in the development and progression of breast cancer (BC), but the clinical significance of angiogenesis-related proteins in metastatic BC remains unknown. This study investigates...